alendronate and adenosine

alendronate has been researched along with adenosine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ellies, LG; Gao, X; Jiang, JX; Riquelme, MA; Sun, LZ; Zhou, JZ1
Arjunji, N; Hoque, J; Newman, H; Sangaj, N; Shih, YV; Varghese, S; Zeng, Y1

Reviews

1 review(s) available for alendronate and adenosine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

3 other study(ies) available for alendronate and adenosine

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Differential impact of adenosine nucleotides released by osteocytes on breast cancer growth and bone metastasis.
    Oncogene, 2015, Apr-02, Volume: 34, Issue:14

    Topics: Adenosine; Adenosine Triphosphate; Alendronate; Animals; Apyrase; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Osteocytes; Receptor, Adenosine A2A; Receptors, Purinergic P2X; RNA Interference; RNA, Small Interfering; Signal Transduction; Transplantation, Heterologous

2015
Bone targeting nanocarrier-assisted delivery of adenosine to combat osteoporotic bone loss.
    Biomaterials, 2021, Volume: 273

    Topics: Adenosine; Alendronate; Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Female; Humans; Mice; Osteoporosis; Ovariectomy; Rats; Rats, Sprague-Dawley; X-Ray Microtomography

2021